Light as a drug: prospective randomized evaluation and comparison of the effect of decreased illumination on visual recovery after cataract surgery.

Purpose: To compare the effect of decreased illumination on the rate of postoperative visual recovery, and the incidence of cystoid macular edema (CME) with surgical visualization achieved with a traditional analog operating microscope compared with a 3D digital visualization system.

Setting: Ambulatory surgery center, New York.

Design: Prospective, randomized, consecutive, single-surgeon series.

Intracanalicular dexamethasone insert for post-corneal crosslinking inflammation and pain: the LINK study.

Purpose: To compare the efficacy of an intracanalicular dexamethasone insert with tapered topical steroid over 28 days after corneal cross-linking (CXL).

Setting: Single private practice, outpatient setting.

Design: Prospective observational randomized study.

In-N-Out technique: double-flanged suture ab interno iridodialysis repair.

In this study, a procedure for iridodialysis repair using an elegant, cost-effective, and quick technique using 6-0 polypropylene sutures, low-temperature electrocautery, and a 27-gauge needle is presented. Previously, all methods required performing a conjunctival peritomy to expose bare sclera and then typically intricate movements and knot tying. The method described in this study combined the sewing machine technique and a modified Yamane scleral-fixation technique to treat iridodialysis that required no knots, peritomies, or specialized equipment.

One-year visual and astigmatic outcomes of keratoconus patients following sequential crosslinking and topography-guided surface ablation: the TOPOLINK study.

Purpose: To evaluate long-term visual and astigmatic outcomes of sequential corneal crosslinking (CXL) followed by topography-guided photorefractive keratectomy (PRK).

Setting: Single-practice outpatient setting.

Design: Retrospective case review.

Visual outcomes, efficacy, and surgical complications associated with intracameral phenylephrine 1.0%/ketorolac 0.3% administered during cataract surgery.

Aim: The purpose of this study was to compare visual outcomes, surgical time, and perioperative surgical complications after intracameral use of either phenylephrine/ketorolac (P/K) or epinephrine (Epi) during cataract surgery.

Methods: This was a single-center, retrospective case review of patients undergoing cataract surgery from August to November 2015. Of the 641 eyes of 389 patients who underwent cataract surgery, 260 eyes were administered phenylephrine 1.

Lifitegrast for the treatment of dry eye disease in adults.

Dry eye disease (DED) is a common ocular disorder that can have a substantial burden on quality of life and daily activities. Lifitegrast ophthalmic solution 5.0% is the first medication approved in the US for the treatment of the signs and symptoms of DED.